Search details
1.
Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.
JCO Precis Oncol
; 6: e2100424, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35138919
Results
1 -
1
de 1
1
Next >
>>